SCHEMBL6786216

SCHEMBL6786216

Nc1c(F)c(F)c(F)c2c1c(=O)c(C(=O)O)c(F)n2C1CC1

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 17/20 0.40
CACNA1F O60840 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
CACNA1D Q01668 1/20 0.39
KCNH2 Q12809 1/20 0.39
CACNA1S Q13698 1/20 0.39
CACNA1C Q13936 1/20 0.39
TOP2A P11388 1/20 0.38
TOP2B Q02880 1/20 0.38
FOXO1 Q12778 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8943879 0.78 TOP2A (0.38) GSK3BCACNA1FPOLBMAPK1CACNA1D
SCHEMBL8741056 0.75 TOP2A (0.40) GSK3BCACNA1FPOLBMAPK1CACNA1D
SCHEMBL1344302 0.74 GSK3B (0.40) GSK3BCACNA1FPOLBMAPK1CACNA1D
SCHEMBL27520234 0.74 NOTUM (0.37) GSK3BCACNA1FPOLBMAPK1CACNA1D
SCHEMBL8120234 0.72 MEN1 (0.36) GSK3BCACNA1FPOLBMAPK1CACNA1D
SCHEMBL1345769 0.72 GSK3B (0.70) GSK3BCACNA1FPOLBMAPK1CACNA1D
SCHEMBL9689537 0.70 GSK3B (0.68) GSK3BCACNA1FPOLBMAPK1CACNA1D
SCHEMBL1342252 0.70 GSK3B (0.44) GSK3BCACNA1FPOLBMAPK1CACNA1D
SCHEMBL8129189 0.69 STAT3 (0.31)
SCHEMBL27610949 0.69 STAT3 (0.36) CACNA1FPOLBMAPK1CACNA1DKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762181-B1 BROAD ANTIBACTERIAL ACTIVITY INCLUDING DRUG RESISTANT STAPHYLOCOCCUS AUREUS (MRSA), PNEUMOCOCCUS (PRSP) AND ENTEROCOCCUS (VRE); SAFELY USED IN CONJUCTION WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-07-13 US disclosed